Despite the importance of PARP1/2 inhibitors (PARPis) in cancer treatment and the growing interest in PARG as a therapeutic target,29,30,31,32 the relative contribution of TARG1 and PARG in the modulation of ADPr levels and cellular homeostasis remains to be elucidated. Here, PARP1 is linked to cancer.